Texas Records First U.S. Measles Death in 10 Years – Epidemiologist Explains How to Protect Against This Preventable Disease

February 28, 2025 UCBN News, Syndication Comments Off on Texas Records First U.S. Measles Death in 10 Years – Epidemiologist Explains How to Protect Against This Preventable Disease
Photo of Dan Pastula, MD with The Conversation logo

On Feb. 26, 2025, Texas health officials announced the death of a child in a measles outbreak – the first measles death in the United States since 2015. The outbreak was first identified in early February in Gaines County, Texas, where just 82% of kindergartners are vaccinated against measles, compared with 93% on average across the country. As of Feb. 27, there were at least 124 confirmed cases in Texas and nearby towns in New Mexico.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

News

Canopy and Rocky Mountain Cancer Centers Announce Multi-Year Partnership to Improve Care with Enterprise AI

July 16, 2026 UCBN News, Syndication Comments Off on Canopy and Rocky Mountain Cancer Centers Announce Multi-Year Partnership to Improve Care with Enterprise AI

NEW YORK, July 16, 2026 /PRNewswire/ — Canopy, the leader in Enterprise AI for oncology, today announced a multi-year partnership with Rocky Mountain Cancer Centers (RMCC), the largest multidisciplinary practice in Colorado dedicated solely to […]

No Picture
News

Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

July 12, 2023 UCBN News, Syndication Comments Off on Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the prospective, real-world ORACLE study (An Observational Registry Study to Evaluate the […]